Related Experiment Video
Updated: Apr 24, 2026

07:08
Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
Published on: August 31, 2022
1.6K
Gemcitabine-induced radiation recall myositis
Joshua Adam Delavan1, Junzo P Chino, Emily N Vinson
1Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC, 27710, USA, jadelava@gmail.com.
Skeletal Radiology
|September 7, 2014
Summary
Radiation recall is a rare inflammatory reaction in irradiated tissues triggered by chemotherapy. This case highlights gemcitabine-induced radiation recall presenting as myositis and dermatitis in a breast cancer patient.
Area of Science:
- Oncology
- Radiology
- Dermatology
Background:
- Radiation recall is an uncommon but recognized phenomenon.
- It involves acute inflammation in previously irradiated tissues following chemotherapy administration.
- This entity is well-documented in oncology but underreported in radiology literature.
Observation:
- A case of gemcitabine-induced radiation recall is presented.
- The patient had a history of radiotherapy for breast cancer metastasis.
- The recall manifested as myositis and dermatitis in the posterior thigh.
Findings:
- Gemcitabine triggered a radiation recall reaction.
- The reaction mimicked inflammatory myositis and dermatitis.
- Imaging findings in radiation recall can be varied and require clinical correlation.
Implications:
- Awareness of radiation recall is crucial for radiologists and oncologists.
- It should be considered in the differential diagnosis of myositis/dermatitis in patients with prior radiotherapy.
- Accurate diagnosis aids in appropriate patient management and treatment planning.
More Related Videos
Related Concept Videos
Biological Effects of Radiation
15.4K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.4K
Myasthenia Gravis: Overview and Treatment
3.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Myasthenia Gravis: Diagnostic Tests
3.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K

